6492.TWO
Price:
$41.6
Market Cap:
$3.72B
Senhwa Biosciences, Inc., a drug development company, engages in the development of new drugs and targeted agents. The company develops CX-5461, a phase I, open-label, dose escalation, safety, pharmacokinetic, and pharmacodynamics study of intravenously administered CX-5461 in patients with advanced hematologic malignancies; CX-5461, which is in a phase I study for solid tumors; CX-5461 that is in a phase Ib expansion study of CX-5461 in patients with solid tumors and BRCA2 and /or PALB2 mutation; and CX-5461, which is in Phase I trial of pidnarulex and talazoparib in patients with metastatic castration resistant prostate cancer. It is also developing CX-4945-CCA that is in phase I/II clinic...[Read more]
Industry
Biotechnology
IPO Date
2014-12-04
Stock Exchange
TWO
Ticker
6492.TWO
According to Senhwa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 38.00. This represents a change of -0.81% compared to the average of 38.31 of the last 4 quarters.
The mean historical Current Ratio of Senhwa Biosciences, Inc. over the last ten years is 32.69. The current 38.00 Current Ratio has changed 11.52% with respect to the historical average. Over the past ten years (40 quarters), 6492.TWO's Current Ratio was at its highest in in the March 2023 quarter at 97.75. The Current Ratio was at its lowest in in the December 2021 quarter at 24.87.
Average
32.69
Median
31.40
Minimum
24.87
Maximum
49.69
Discovering the peaks and valleys of Senhwa Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.85%
Maximum Annual Current Ratio = 49.69
Minimum Annual Increase = -36.82%
Minimum Annual Current Ratio = 24.87
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 33.29 | 6.02% |
| 2023 | 31.40 | -36.82% |
| 2022 | 49.69 | 99.85% |
| 2021 | 24.87 | -36.08% |
| 2020 | 38.90 | 34.29% |
| 2019 | 28.97 | -14.62% |
| 2018 | 33.93 | 21.33% |
| 2017 | 27.96 | 10.72% |
The current Current Ratio of Senhwa Biosciences, Inc. (6492.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
38.13
5-year avg
35.63
10-year avg
32.69
Senhwa Biosciences, Inc.’s Current Ratio is greater than Formosa Pharmaceuticals, Inc. (9.57), greater than Energenesis Biomedical CO.,LTD. (34.47), greater than Medigen Biotechnology Corp. (5.12), greater than BRIM Biotechnology, Inc. (5.18), greater than AnnJi (4.99), greater than TWi Biotechnology, Inc. (2.78), greater than UnicoCell Biomed Co., Ltd. (35.10), greater than Orient EuroPharma Co., Ltd. (1.65), greater than Synbio Tech Inc. (1.46), greater than Syngen Biotech Co.,Ltd. (2.06),
| Company | Current Ratio | Market cap |
|---|---|---|
| 9.57 | $4.02B | |
| 34.47 | $3.81B | |
| 5.12 | $4.40B | |
| 5.18 | $3.85B | |
| 4.99 | $4.86B | |
| 2.78 | $1.77B | |
| 35.10 | $4.78B | |
| 1.65 | $3.77B | |
| 1.46 | $3.08B | |
| 2.06 | $3.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senhwa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Senhwa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Senhwa Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Senhwa Biosciences, Inc. (6492.TWO)?
What is the highest Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?
What is the 3-year average Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?
What is the 5-year average Current Ratio for Senhwa Biosciences, Inc. (6492.TWO)?
How does the current Current Ratio for Senhwa Biosciences, Inc. (6492.TWO) compare to its historical average?